| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CFO
2 companies
Andrews Julie is a CFO at OFIX, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 6 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Andrews Julie a middling insider score of 55/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +29.5%.
Andrews Julie's largest disclosed position is in OFIX as CFO, worth about $1.1M. The recent filings there lean toward selling, a net 14,316 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | OFIX Orthofix Medical Inc. | CFO | Sell | 4,788 | $12.74 | $60,979.57 | -5.1% | -22.7% | - | |
| Jan 16, 2026 | OFIX Orthofix Medical Inc. | CFO | Sell | 4,873 | $14.38 | $70,073.74 | -7.7% | -11.8% | - | |
| Jan 16, 2025 | OFIX Orthofix Medical Inc. | CFO | Sell | 4,655 | $17.89 | $83,277.95 | -14.1% | -27.7% | -21.6% | |
| Jun 14, 2024 | RXST Rxsight, Inc. | Director | Sell10b5-1 | 15,625 | $58.00 | $906,288.14 | -34.0% | -5.8% | -75.5% | |
| Aug 3, 2021 | RXST Rxsight, Inc. | Director | Buy | 15,625 | $16.00 | $250,000.00 | +116.8% | -28.2% | -8.6% |